KYMR Operating Cash Flow (Statement)

Kymera Therapeutics Inc · Operating Cash Flow (Statement)

KYMR logo

KYMR Operating Cash Flow (Statement)

Latest reported-$54.07M
KYMR Quarterly Cash from Operations (-$12.47M → -$54.07M)
High-resolution chart · PNG

KYMR operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-54,065,000
-88,840,000
-66,747,000
-27,110,000
-59,884,000
-79,150,000
-61,784,000
-50,190,000
-42,936,000
-39,591,000
8,045,000
-31,647,000
-35,256,000
-43,968,000
-39,536,000
-34,269,000
-38,985,000
-40,295,000
-38,352,000
-37,260,000
-30,511,000
-22,823,000
-20,068,000
131,667,000
-11,412,000
-12,057,000
-10,801,000
-12,474,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.